Goji

Umxholo

• Akukho bungqina baneleyo bokulinganisa ukusebenza ...
• Amanyathelo okhuseleko kunye nezilumkiso:

IGoji sisityalo esikhula kummandla weMeditera kunye neendawo zaseAsia. Amaqunube kunye neengcambu zisetyenziselwa ukwenza amayeza.

IGoji isetyenziselwa iimeko ezininzi kubandakanya isifo seswekile, ukwehla kobunzima, ukuphucula umgangatho wobomi, kunye neetoni, kodwa abukho ubungqina benzululwazi obuxhasa nayiphi na kwezi zinto zisetyenziswayo.

Ekutyeni, amaqunube atyiwa ekrwada okanye asetyenziswa ekuphekeni.

Amayeza endalo aVimba weDatha Ukusebenza kwexabiso ngokusekwe kubungqina besayensi ngokwala manqanaba alandelayo: Ukusebenza, ukusebenza ngokukuko, okunokwenzeka ukuba kusebenze, okungenzeka kungasebenzi, kunokwenzeka ukungasebenzi, ukungasebenzi, kunye nobungqina obungonelanga bokulinganisa.

Ukulinganiswa kokusebenza kwe GOJI zezi zilandelayo:

Akukho bungqina baneleyo bokulinganisa ukusebenza ...

• Seswekile. Uphando lwakwangoko lubonisa ukuba ukuthatha iikhabhohayidrethi kwiziqhamo zejiji kabini ngemini kangangeenyanga ezi-3 kunciphisa iswekile yegazi emva kokutya kubantu abanesifo seswekile. Kungasebenza ngcono kubantu abangathathi nyango lweswekile.
• Amehlo omileyo. Uphando lwakwangoko lubonisa ukuba ukusebenzisa amathontsi wamehlo kunye nokusela isiselo esineziqhamo zeji kunye nezinye izithako zenyanga enye kunokuphucula iimpawu zamehlo owomileyo ngcono kunokusebenzisa amathontsi wamehlo wedwa. Ayaziwa ukuba isibonelelo singenxa yeziqhamo zejiji, ezinye izinto, okanye indibaniselwano.
• Umgangatho wobomi. Olunye uphando lwakwangoko lubonisa ukuba ukusela ijusi yejiji ukuya kuthi ga kwiintsuku ezingama-30 kuphucula umgangatho wobomi obahlukeneyo. Amandla, umgangatho wokulala, ukusebenza kwengqondo, ukuhlala rhoqo emathunjini, imood, kunye neemvakalelo zokwoneliseka zibonakala ziphucuka. Imemori yexesha elifutshane kunye namehlo awenzi.
• Ukuhla ukusinda. Uphando lwakwangoko lubonisa ukuba ukusela ijiji yejusi iiveki ezi-2 ngelixa ukutya ukutya kunye nokwenza umthambo kunciphisa ubungakanani besinqe kubantu abadala abangaphezulu komzimba kunendlela yokutya kunye nokuzilolonga wedwa. Kodwa ukusela ijusi akuqhubeki ukuphucula ubunzima okanye amanqatha omzimba.
• Iingxaki zokuhamba kwegazi.
• Umhlaza.
• Ukuba nesiyezi.
• Ifiva.
• Igazi elonyukayo.
• Isifo seengcongconi.
• Ukukhala ezindlebeni (tinnitus).
• Iingxaki zesondo (ukungabi namandla).
• Ezinye iimeko.

Ubungqina obungakumbi buyafuneka ukukala ukusebenza kweGoji kwezi zinto zisetyenziswayo.

IGoji iqulethe iikhemikhali ezinokunceda ukunciphisa uxinzelelo lwegazi kunye neswekile yegazi. I-Goji inokunceda ekuvuseleleni amajoni omzimba kunye nokukhusela amalungu kumonakalo we-oxidative.

UGoji unjalo UKHUSELEKO OLUNOKWENZEKA xa kuthathwe ngokufanelekileyo ngomlomo, ixesha elifutshane. Isetyenziswe ngokukhuselekileyo ukuya kwiinyanga ezi-3. Kwiimeko ezinqabileyo kakhulu, iziqhamo zegoji zinokubangela ukwanda kokuziva elangeni, ekonakaleni kwesibindi, kunye neempendulo ezithile.

Amanyathelo okhuseleko kunye nezilumkiso:

Ukukhulelwa kunye nokuncancisa: Akonelanga ngokwaziwayo malunga nokukhuseleka kokusebenzisa goji ngexesha lokukhulelwa kunye nokuncancisa. Kukho inkxalabo yokuba iziqhamo zegoji zinokubangela ukuba isibeleko singene kwisivumelwano. Kodwa oku akuxelwanga ebantwini. Kude kube kwaziwa ngakumbi, hlala kwicala elikhuselekileyo kwaye uphephe ukusetyenziswa.

Ukwehla komzimba kwiiprotheyini kwiimveliso ezithile: I-Goji inokubangela ukuba abantu bangadibani necuba, iipesika, iitumato kunye namandongomane.

Seswekile: IGoji inokunciphisa iswekile yegazi. Isenokubangela ukuba iswekile yegazi yehle kakhulu ukuba uthatha amayeza eswekile. Jonga amanqanaba eswekile yegazi ngononophelo.

Uxinzelelo lwegazi oluphantsi: IGoji inokuhlisa uxinzelelo lwegazi. Ukuba uxinzelelo lwegazi sele luphantsi, ukuthatha i-goji kunokuyenza ilahle kakhulu.

Iphakathi

Lumka ngale nhlanganisela.

Amayeza atshintshwe sisibindi (iiCytochrome P450 2C9 (CYP2C9) substrates)

Amanye amayeza atshintshiwe kwaye aphulwe sisibindi. IGoji inokunciphisa ngokukhawuleza ukuba isibindi siwaphula amayeza. Ukuthatha i-goji kunye namanye amayeza aphulwe sisibindi kunokunyusa iziphumo kunye neziphumo zamayeza athile. Ngaphambi kokuba uthathe i-goji, thetha nomboneleli wakho wezempilo ukuba uthatha nawaphi na amayeza atshintshwa sisibindi.

Amanye amayeza atshintshwa sisibindi abandakanya i-amitriptyline (Elavil), diazepam (Valium), zileuton (Zyflo), celecoxib (Celebrex), diclofenac (Voltaren), fluvastatin (Lescol), glipizide (Glucotrol), ibuprofen (Advil, Motrin) , irbesartan (Avapro), losartan (Cozaar), phenytoin (Dilantin), piroxicam (Feldene), tamoxifen (Nolvadex), tolbutamide (Tolinase), torsemide (Demadex), warfarin (Coumadin) nabanye.

Amayeza eswekile (iziyobisi zeAntidiabetes)

UGoji unokunciphisa iswekile yegazi. Amayeza eswekile asetyenziselwa ukunciphisa iswekile yegazi. Ukuthatha i-goji kunye namayeza eswekile kunokubangela ukuba iswekile egazini lakho lihle kakhulu. Jonga eswekile yegazi lakho ngokusondeleyo. Umthamo weyeza lakho leswekile unokufuna ukuba utshintshwe.

Amanye amayeza asetyenziselwa isifo seswekile aquka i-glimepiride (Amaryl), i-glyburide (i-DiaBeta, i-Glynase PresTab, i-Micronase), i-insulin, i-pioglitazone (i-Actos), i-rosiglitazone (i-Avandia), i-chlorpropamide (i-Diabinese), i-glipizide (i-Glucotrol), i-tolbutamide (i-Orinase), .

Amayeza oxinzelelo lwegazi oluphezulu (iziyobisi ezichasayo)

Ingcambu yeGoji ibonakala inciphisa uxinzelelo lwegazi. Ukuthatha i-goji yengcambu ye-bark kunye namayeza oxinzelelo lwegazi kunokubangela ukuba uxinzelelo lwegazi luye phantsi kakhulu. Isiqhamo seGoji asibonakali sichaphazela uxinzelelo lwegazi.

Amanye amayeza oxinzelelo lwegazi aphezulu abandakanya i-captopril (Capoten), enalapril (Vasotec), losartan (Cozaar), valsartan (Diovan), diltiazem (Cardizem), Amlodipine (Norvasc), hydrochlorothiazide (HydroDIURIL), furosemide (Lasix), kunye nabanye abaninzi. .

IWarfarin (Coumadin)

IWarfarin (Coumadin) isetyenziselwa ukucothisa ukujiya kwegazi. IGoji inokunyusa ukuba i-warfarin (Coumadin) ide kangakanani emzimbeni. Oku kunokunyusa amathuba okugruzuka nokopha. Qiniseka ukuba igazi lakho lihlolwe rhoqo. Umthamo we-warfarin yakho (Coumadin) unokufuna ukutshintsha.

Iherbs kunye nezongezo ezinokunciphisa uxinzelelo lwegazi

Ingcambu yeGoji inganciphisa uxinzelelo lwegazi. Ukuyisebenzisa kunye namanye amayeza kunye nokuncedisa ukunciphisa uxinzelelo lwegazi kunokunciphisa uxinzelelo lwegazi kakhulu. Ezinye zeemveliso zibandakanya i-danshen, ijinja, iPanax ginseng, turmeric, valerian, kunye nezinye.

Iherbs kunye nezongezo ezinokunciphisa iswekile yegazi

UGoji unokunciphisa iswekile yegazi. Ukuyisebenzisa kunye namanye amayeza kunye nezongezo ezenza iswekile esezantsi yegazi isenokunciphisa iswekile yegazi kakhulu. Ezinye zeemveliso zibandakanya i-melon ekrakra, ijinja, irue yebhokhwe, i-fenugreek, i-kudzu, i-willow bark, kunye nezinye.

Akukho kunxibelelana kwaziwayo nokutya.

Idosi efanelekileyo yegoji ixhomekeke kwizinto ezininzi ezinje ngeminyaka yomsebenzisi, impilo, kunye nezinye iimeko. Ngeli xesha akukho lwazi lwaneleyo lwesayensi ukumisela uluhlu olufanelekileyo lweedosi zegoji. Gcina ukhumbula ukuba iimveliso zendalo azisoloko zikhuselekile kwaye iidosi zibalulekile. Qiniseka ukuba ulandela umkhombandlela ofanelekileyo kwiilebheli zemveliso kwaye uqhagamshelane nosokhemesti okanye ugqirha okanye olunye uqeqesho kwezempilo ngaphambi kokusebenzisa.

Baies de Goji, Baies de Lycium, Barberry Matrimony Vine, Chinese Boxthorn, Chinese Wolfberry, Di Gu Pi, Digupi, Épine du Christ, Fructus Lychii Chinensis, Fructus Lycii, Fructus Lycii Berry, Fruit de Lycium, Goji, Goji Berry, Goji Chinois , Goji de l'Himalaya, Goji Juice, Gougi, Gou Qi Zi, Gouqizi, Jus de Goji, Kuko, Lichi, Licium Barbarum, Litchi, Lyciet, Lyciet Commun, Lyciet de Barbarie, Lyciet de Chine, Lycii Berries, Lycii Chinensis, Isiqhamo seLycii, i-Lycium barbarum, i-Lycium chinense, i-Lycium Fruit, i-Matrimony Vine, i-Ning Xia Gou Qi, i-Wolfberry, i-Wolf berry.

Ukuze ufunde okungakumbi malunga nokubhalwa kweli nqaku, nceda ubone Amayeza endalo aVimba weDatha indlela yokusebenza.

1. I-Potterat O. Goji (iLiccium barbarum kunye neL. Chinense): I-Phytochemistry, ikhemesti kunye nokhuseleko ngokwembono yosetyenziso lwemveli kunye nokuthandwa kwamva nje. IPlanta Med 2010; 76: 7-19. Jonga i-abstract.
2. UCheng J, uZhou ZW, uSheng HP, yena uLJ, uFan XW, yena uZX, et al. Uhlaziyo olusekwe kubungqina kwimisebenzi ye-pharmacological kunye neethagethi ezinokubakho zeLycium barbarum polysaccharides. Iziyobisi Des Desvel Ther. Ngo-2014; 17: 33-78. Jonga i-abstract.
3. Cai H, Liu F, Zuo P, Huang G, Ingoma Z, Wang T, et al. Ukusetyenziswa ngokukuko kokusebenza kwe-antidiabetic yeLycium barbarum polysaccharide kwizigulana ezinesifo seswekile sesi-2. IMed Chem. Ngo-2015; 11: 383-90. Jonga i-abstract.
4. ILarramendi CH, uGarcía-Abujeta JL, uVicario S, uGarcía-Endrino A, uLópez-Matas MA, uGarcía-Sedeño MD, et al. Amajikijolo eGoji (iLiccium barbarum): Umngcipheko wokungaziphathi kakuhle kubantu abanokutya komzimba. J Uphando lweAllergol kwiklinikhi ye-Immunol. Ngo-2012; 22: 345-50. Jonga i-abstract.
5. UJiménez-Encarnación E, uRíos G, uMunoz-Mirabal A, uVilá LM. I-Euforia-indened hepatitis ebukhali kwisigulana esine-scleroderma. I-BMJ Case Rep 2012; 2012. Jonga i-abstract.
6. Amagase H, Ilanga B Nance DM. Izifundo zeklinikhi zokuphucula impilo ngokubanzi ngesiqhelo esimiselweyo sejusi yeLycium barbarum. IPlanta Med 2008; 74: 1175-1176.
7. UKim, H. P., Kim, S. Y., Lee, E. J., Kim, YC, kunye noKim, uY.C. Res Commun. UMol. Pathol Pharmacol 1997; 97: 301-314. Jonga i-abstract.
8. I-Gribanovski-Sassu, O., Pellicciari, R., kunye neCataldi, Hiughez C. Igqabi le-Lycium europaeum: isiphumo sexesha kwi-zeaxanthin kunye ne-lutein. UAnn Ist Super uSanita 1969; 5: 51-53. Jonga i-abstract.
9. Wineman, E., Portugal-Cohen, M., Soroka, Y., Cohen, D., Schlippe, G., Voss, W., Brenner, S., Milner, Y., Hai, N., kunye noMa ' okanye, Z. Ifoto-yokonakalisa isiphumo sokukhusela iimveliso ezimbini zobuso, eziqulathe ubunzima obukhethekileyo bezimbiwa zoLwandle oluFileyo kunye neentshukumo zeHimalaya. J.Cosmet, iDermatol. Ngo-2012; 11: 183-192. Jonga i-abstract.
10. UPaul Hsu, uC. H., uNance, uD. M., kunye no-Amagase, uH. Ukutya J. J. 2012; 15: 1006-1014. Jonga i-abstract.
11. UFranco, M., Monmany, J., Domingo, P., kunye noTurbau, M. [Ukuzibulala kwe-hepatitis okuzenzekelayo okubangelwa kukusetyenziswa kwamajikijolo eGoji]. I-Med. Zonyango. (Barc. 9-22-2012; 139: 320-321. Jonga i-abstract.
12. UVidal, K., Bucheli, P., Gao, Q., Moulin, J., Shen, LS, Wang, J., Blum, S., kunye neBenyacoub, J.Iziphumo zokunganyanzeliswa kokutya kokutya kunye ne-wolfberry esekwe kubisi ukwenziwa kubantu abadala abasempilweni: ityala elilawulwa ngokungahleliwe, elingaboniyo, elilawulwa yi-placebo. Ukuhlaziywa kwakhona. Ngo-2012; 15: 89-97. Jonga i-abstract.
13. UMonzon, uBallarin S., uLopez-Matas, uM A., uSaenz, u-Abad D., uPerez-Cinto, uN, noCarnes, uJ. Anaphylaxis enxulunyaniswa nokufakwa kwamajikijolo eGoji (ILiccium barbarum). J. Uphando, Allergol. Clin. Imunol. Ngo-2011; 21: 567-570. Jonga i-abstract.
14. Isono, H. P., Liu, D., kunye neLam, D. S. Ukulungiswa kwendlela yokuphila, ukutya okunesondlo kunye neevithamini zokongeza ukwanda okuhambelana nobudala be-macular. U-Acta Ophthalmol. Ngo-2013; 91: 6-11. Jonga i-abstract.
15. Amagase, H. kunye noNance, D. M. I-Lycium barbarum yonyusa inkcitho yekhalori kunye nokunciphisa ukujikeleza kwesinqe kumadoda nabafazi abasempilweni: isifundo somqhubi. UJ Am Coll. Umsoco. Ngo-2011; 30: 304-309. Jonga i-abstract.
16. I-Bucheli, P., Vidal, K., Shen, L., Gu, Z., Zhang, C., Miller, L. E., kunye noWang, J. Goji berry ifuthe kwiimpawu ze-macular kunye namanqanaba e-plasma antioxidant. I-Optom.Vis.Sci. Ngo-2011; 88: 257-262. Jonga i-abstract.
17. Amagase, H., Ilanga, B., kunye neNance, D. M.Iziphumo zokungafunyanwanga emzimbeni kwincindi yesiqhamo seLycium barbarum kwizifundo zabantu abadala baseTshayina. Ukutya ku-J.Med 2009; 12: 1159-1165. Jonga i-abstract.
18. Wei, D., Li, Y.H, kunye noZhou, W.Y. Zhongguo Zhong.Xi.Yi.Jie.Iye.Za Zhi. Ngo-2009; 29: 646-649. Jonga i-abstract.
19. UMiao, Y., Xiao, B., Jiang, Z., Guo, Y., Mao, F., Zhao, J., Huang, X., kunye noGoo, J. Ukukhula kuthintelo kunye nokubanjwa komjikelo weseli esiswini somntu. iiseli zomhlaza nguLiccium barbarum polysaccharide. Imbali yeOncol. Ngo-2010; 27: 785-790. Jonga i-abstract.
20. Amagase, H., Ilanga, B., kunye neBorek, C. I-Lycium barbarum (goji) ijusi iphucula kwi-vivo antioxidant biomarkers kwi-serum yabantu abadala abasempilweni. Isondlo Res. I-2009; 29: 19-25. Jonga i-abstract.
21. Lu, C. X. kunye noCheng, B. Q. [Radiosensitizing effects of Lycium barbarum polysaccharide for Lewis lung cancer]. Zhong. Xi.Yi.Jie.Iye.Za Zhi. Ngo-1991; 11: 611-2, 582.
22. U-Chang, R. C. kunye no-So, u-K.F Ukusetyenziswa kweyeza lokuGuga ngamayeza e-Herbal, i-Lycium barbarum, ngokuchasene nezifo ezihambelana nokwaluphala. Yintoni esiyaziyo ukuza kuthi ga ngoku? Iseli Mol. 8-21-2007; Jonga i-abstract.
23. I-Chan, HC, i-Chang, i-RC, i-Koon-Ching, i-Ip A., i-Chiu, i-K., i-Yuen, i-WH, i-Zee, i-SY, kunye ne-KF Neuroprotective ye-Lycium barbarum Lynn ekukhuseleni iiseli ze-retinal ganglion kwiimodeli zoxinzelelo iglaucoma. Exp Neurol. Ngo-2007; 203: 269-273. Jonga i-abstract.
24. I-Adams, M., Wiedenmann, M., Tittel, G., kunye neBauer, R. HPLC-MS ukulandelela uhlalutyo lwe-atropine kwiLiccium barbarum berries. Unyango. Ngo-2006; 17: 279-283. Jonga i-abstract.
25. UChao, J. C., Chiang, S. W., Wang, C., Tsai, YH, kunye noWu, M. S. Amanzi ashushu akhutshwe yiLycium barbarum kunye neRehmannia glutinosa inqanda ukwanda kunye nokwenza iapoptosis yeeseli ze-hepatocellular carcinoma. Ihlabathi J Gastroenterol 7-28-2006; 12: 4478-4484. Jonga i-abstract.
26. Benzie, I. F., Chung, W. Y., Wang, J., Richelle, M., kunye neBucheli, P. Ukuphuculwa kokufumaneka kwe-zeaxanthin kulwakhiwo olusekwe kubisi lwewolfberry (Gou Qi Zi; Fructus barbarum L.). Br J Amanqaku 2006; 96: 154-160. Jonga i-abstract.
27. Yu, M. S., Ho, Y. S., Ke, K. F., Yuen, W. H., kunye no-Chang, R. C. Iziphumo zokuvikela ukukhusela i-Lycium barbarum ngokuchasene nokunciphisa uxinzelelo kwi-endoplasmic reticulum. I-Int J Mol. Phakathi ngo-2006; 17: 1157-1161. Jonga i-abstract.
28. UPeng, Y., Ma, C., Li, Y., Leung, K. S., Jiang, Z. H., kunye noZhao, Z. Ubungakanani be-zeaxanthin dipalmitate kunye ne-carotenoids iyonke kwiziqhamo zeLiccium (Fructus Lycii). Ukutya kwezityalo Hum. Nutrut 2005; 60: 161-164. Jonga i-abstract.
29. UZhao, R., Li, Q., kunye noXiao, B. Iziphumo zeLiccium barbarum polysaccharide ekuphuculeni ukunganyangeki kwe-insulin kwiigundane ze-NIDDM. Yakugaku Zasshi 2005; 125: 981-988. Jonga i-abstract.
30. I-Toyada-Ono, Y., Maeda, M., Nakao, M., Yoshimura, M., Sugiura-Tomimori, N., Fukami, H., Nishioka, H., Miyashita, Y., kunye noKojo, S. A. Inoveli ye-vitamin C ye-analog, 2-O- (beta-D-Glucopyranosyl) ascorbic acid: uvavanyo lwe-enzymatic synthesis kunye nomsebenzi we-biological. J Biosci, iBioeng. Ngo-2005; 99: 361-365. Jonga i-abstract.
31. U-Lee, D. G., Jung, H. J., kunye no-Woo, E. R. Ipropathi ye-Antimicrobial ye (+) - lyoniresinol-3alpha-O-beta-D-glucopyranoside ekhethwe kwingcambu yeLiccium chinense Miller ngokuchasene neentsholongwane zabantu. IArch Pharm Res 2005; 28: 1031-1036. Jonga i-abstract.
32. He, Y. L., Ying, Y., Xu, Y. L., Su, J. F., Luo, H., noWang, H. F. [Iziphumo zeLiccium barbarum polysaccharide kwi-tumor microenvelo T-lymphocyte subsets kunye neeseli zedendritic kwiimpuku ze-H22]. Zhong. Xi.Yi.Jie.Iye.Xue.Bao. 2005; 3: 374-377. Jonga i-abstract.
33. UGong, H., Shen, P., Jin, L., Xing, C., kunye noTang, F. Iziphumo zonyango lweLycium barbarum polysaccharide (LBP) kwimitha ye-radiation okanye ye-chemotherapy-indised myelosuppressive. Umhlaza Biother.Radiopharm. Ngo-2005; 20: 155-162. Jonga i-abstract.
34. UZhang, M., Chen, H., Huang, J., Li, Z., Zhu, C., kunye noZhang, S. Iziphumo ze-lycium barbarum polysaccharide kwi-hepatoma QGY7703 yeeseli: ukuthintela ukwanda kunye nokungeniswa kwe-apoptosis. Ubomi beSayensi 3-18-2005; 76: 2115-2124. Jonga i-abstract.
35. I-Hai-Yang, G., Ping, S., Li, J. I., Chang-Hong, X., kunye neFu, T. Iziphumo zonyango zeLycium barbarum polysaccharide (LBP) kwi-mitomycin C (MMC) yeempuku ze-myelosuppressive. UJ Exp Ther Oncol 2004; 4: 181-187. Jonga i-abstract.
36. UCheng, C. Y., Chung, W. Y., Szeto, Y.T, noBenzie, I. F. Ukuzila ukutya kwe-plasma zeaxanthin kwimpendulo kaFructus barbarum L. (wolfberry; Kei Tze) kulingo lokutya olusekwe kuluntu. Br. J Isondlo. 2005; 93: 123-130. Jonga i-abstract.
37. UZhao, H., Alexeev, A., Chang, E., Greenburg, G., kunye noBojanowski, K. ILycium barbarum glycoconjugates: ifuthe kulusu lomntu kunye ne-dermal fibroblast ekhulileyo. IPhytomedicine 2005; 12 (1-2): 131-137. Jonga i-abstract.
38. I-Luo, Q., Cai, Y., Yan, J., Sun, M., kunye noCorke, H. Hypoglycemic kunye neempembelelo ze-hypolipidemic kunye nomsebenzi we-antioxidant weziqhamo ezivela kwiLycium barbarum. Ubomi beSayensi 11-26-2004; 76: 137-149. Jonga i-abstract.
39. U-Lee, D. G., Park, Y., Kim, M. R., Jung, H. J., Seu, Y. B., Hahm, K. S., kunye no-Woo, E. R. Iziphumo ezichasene nokungunda kwe-phenolic amides ezikwingcambu ye-Lycium chinense. Biotechnol.Lett 2004; 26: 1125-1130. Jonga i-abstract.
40. UBreithaupt, DE, Weller, P., Wolters, M., kunye noHahn, A. Thelekisa iimpendulo zeplasma kwizifundo zabantu emva kokufakwa kwe-3R, 3R'-zeaxanthin dipalmitate from wolfberry (ILiccium barbarum) kunye ne-3R, 3R engafakwanga. '-zeaxanthin usebenzisa i-chiral ephezulu yokusebenza kolwelo chromatography. Br. J Isondlo. Ngo-2004; 91: 707-713. Jonga i-abstract.
41. Gan, L., Hua, Zhang S., Liang, Yang, X, kunye no-Bi, Xu H.Ukuchaphazeleka komzimba kunye nomsebenzi we-antitumor yi-polysaccharide-protein tata evela eLycium barbarum. Int Immunopharmacol. Ngo-2004; 4: 563-569. Jonga i-abstract.
42. I-Toyoda-Ono, Y., Maeda, M., Nakao, M., Yoshimura, M., Sugiura-Tomimori, N., kunye noFukami, H. 2-O- (beta-D-Glucopyranosyl) ascorbic acid, inoveli. i-ascorbic acid analogue ehlukaniswe neziqhamo zeLycium. J Agric Ukutya Chem 4-7-2004; 52: 2092-2096. Jonga i-abstract.
43. U-Huang, X., Yang, M., Wu, X., kunye no-Yan, J. [Isifundo malunga nokukhusela i-lycium barbarum polysaccharides kwii-DNA zokufakwa kweeseli zamatyhalarha kwiimpuku]. Wei Sheng Yan. Jiu. Ngo-2003; 32: 599-601. Jonga i-abstract.
44. I-Luo, Q., Yan, J., kunye neZhang, S. [Ukuqhawulwa kunye nokuhlanjululwa kweLycium barbarum polysaccharides kunye nefuthe layo lokuthintela ukudinwa]. Wei Sheng Yan. Jiu. 3-30-2000; 29: 115-117. Jonga i-abstract.
45. UGan, L., Wang, J., kunye noZhang, S. [Ukuthintela ukukhula kweeseli zomhlaza wegazi ngeLiccium barbarum polysaccharide]. Wei Sheng Yan. Jiu. 2001; 30: 333-335. Jonga i-abstract.
46. Liu, X. L., Sun, J. Y., Li, H. Y., Zhang, L., kunye noQian, B. C. [Ukukhutshwa kunye nokubekwa ecaleni kwento esebenzayo yokuthintela ukwanda kweeseli ze-PC3 kwi-vitro kwiziqhamo zeLiccium barbarum L.]. Zhongguo Zhong.Yao Za Zhi. Ngo-2000; 25: 481-483. Jonga i-abstract.
47. I-Chin, Y. W., Lim, S. W., Kim, S.H, Shin, D.Y., Suh, Y. G., Kim, Y. B., Kim, YC, kunye noKim, J.Hepatoprotective pyrrole derivatives zeziqhamo zeLiccium. UMedi Chem Lett 1-6-2003; 13: 79-81. Jonga i-abstract.
48. U-Wang, Y., Zhao, H., Sheng, X., Gambino, P. E., Costello, B., kunye noBojanowski, K. J U-Ethnopharmacol. Ngo-2002; 82 (2-3): 169-175. Jonga i-abstract.
49. U-Huang, Y., Lu, J., Shen, Y., kunye no-Lu, J. [Iziphumo zokuzikhusela ze-flavonoids zizonke ezivela kwi-Lycium Barbarum L. kwi-lipid peroxidation ye-mitochondria yesibindi kunye neeseli ezibomvu zegazi kwiigundane]. Wei Sheng Yan. Jiu. 3-30-1999; 28: 115-116. Jonga i-abstract.
50. UKim, H. P., Lee, E. J., Kim, YC, uKim, uJ., UKim, uHK, uPaki, uJ. H., uKim, uS., NoKim, uY. IBiol Pharm Bull. Ngo-2002; 25: 390-392. Jonga i-abstract.
51. UKim, S.Y., Lee, E. J., Kim, H. P., Kim, Y.C, uNyanga, A., noKim, uY.C Incwadana yecerebroside evela kwi-lycii fructus igcina inkqubo ye-hepatic glutathione redox kwiinkcubeko eziphambili zeepat hepatocytes. IBiol Pharm Bull. Ngo-1999; 22: 873-875. Jonga i-abstract.
52. Fu, J. X. [Ukulinganiswa kwe-MEFV kumatyala angama-66 esifuba kwinqanaba lokuchacha nasemva konyango ngamayeza amaTshayina]. Zhong. Xi.Yi.Jie.Iye.Za Zhi. Ngo-1989; 9: 658-9, 644.
53. I-Weller, P. kunye neBreithaupt, D. E. Ukuchongwa kunye nokuchazwa kweestax ze-zeaxanthin kwizityalo zisebenzisa i-chromatography-mass spectrometry yolwelo. Ukutya Chem. 11-19-2003; 51: 7044-7049. Jonga i-abstract.
54. UGomez-Bernal, S., Rodriguez-Pazos, L., Martinez, F. J., Ginarte, M., Rodriguez-Granados, M.T, kunye noToribio, J. Inkqubo ye-photosensitivity ngenxa yamajikijolo eGoji. Photodermatol.Photoimmunol.Ifoto. Ngo-2011; 27: 245-247. Jonga i-abstract.
55. ILarramendi, CH, Garcia-Abujeta, JL, Vicario, S., Garcia-Endrino, A., Lopez-Matas, MA, Garcia-Sedeno, MD, kunye neeCarnes, J. Goji amajikijolo (ILiccium barbarum): umngcipheko wokuphendula kubantu abanokutya kokutya. UJ.Investig, Allergol kunye neKlinikhi. Ngo-2012; 22: 345-350. Jonga i-abstract.
56. Iicarnes, J., de Larramendi, CH, Ferrer, A., Huertas, AJ, Lopez-Matas, MA, iPagan, JA, Navarro, LA, Garcia-Abujeta, JL, Vicario, S., kunye nePena, M. Kutshanje. ukwazisa ukutya njengemithombo emitsha ye-allergenic: uvakalelo kumajikijolo eGoji (iLiccium barbarum). Ukutya Chem. 4-15-2013; 137 (1-4): 130-135. Jonga i-abstract.
57. URivera, uC. A., uFerro, uC. L., uBursua, uA, noGerber, uB S. Ukudibana okunokwenzeka phakathi kweLiccium barbarum (goji) kunye ne-warfarin. I-Pharmacotherapy 2012; 32: e50-e53. Jonga i-abstract.
58. Amagase H, Nance DM. Ukulawulwa okungahleliwe, okungaboniyo, okulawulwa yi-placebo, ukufundwa kweklinikhi yeziphumo eziqhelekileyo zejusi ye-Lycium barbarum (goji) esemgangathweni, iGoChi. J enye into yokuGqibezela iMed 2008; 14: 403-12. Jonga i-abstract.
59. Leung H, Hung A, Hui AC, Chan TY. Ukugqithisa kweWarfarin ngenxa yeziphumo ezinokubakho zeLycium barbarum L. Ukutya Chem Toxicol 2008; 46: 1860-2. Jonga i-abstract.
60. ILam AY, i-Elmer GW, iMohutsky MA. Unxibelelwano olunokwenzeka phakathi kwe-warfarin kunye neLycium Barbarum. UAnn Pharmacother 2001; 35: 1199-201. Jonga i-abstract.
61. Huang KC. Unyango lwamayeza amaTshayina. Ngomhla wesi-2. IBoca Raton, FL: ICR Press, LLC 1999.
62. UKim SY, uLee EJ, uKim HP, et al. I-LCC, i-cerebroside evela kwi-lycium chinense, ikhusela i-rat hepatocyte ezisisiseko ezivezwe kwi-galactosamine. UPhytother Res 2000; 14: 448-51. Jonga i-abstract.
63. Cao GW, Yang WG, Du P. [Ukuqwalaselwa kweziphumo zonyango lwe-LAK / IL-2 oludibanisa neLycium barbarum polysaccharides kunyango lwezigulana ezingama-75 zomhlaza]. UChung Hua Chung Liu Tsa Chih 1994; 16: 428-31.Jonga i-abstract.
64. Inkonzo yoPhando lwezoLimo. Ugcino lukaDkt.Duke's phytochemical kunye ethnobotanical database. www.ars-grin.gov/cgi-bin/duke/farmacy2.pl?575 (Ifumaneka nge-31 Januwari 2001).
65. I-Chevallier A. Encyclopedia yamayeza e-Herbal. Ngomhla wesi-2. ENew York, NY: DK Publ, Inc., 2000.
66. Umthetho M. Tyala i-sterol kunye ne-stanol margarines kunye nempilo. BMJ 2000; 320: 861-4. Jonga i-abstract.
67. UMcGuffin M, uHobbs C, u-Upton R, uGoldberg A, ii-eds. Incwadana yokhuseleko lwezityalo yaseMelika. IBoca Raton, FL: ICR Press, LLC 1997.

Ukuhlaziywa kokugqibela-04/03/2019